Download presentation
Presentation is loading. Please wait.
Published byCoral Holland Modified over 9 years ago
1
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 45 Immunosuppressant Drugs
2
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Immune System Defends the body against invading pathogens, foreign antigens, and its own cells that become cancerous Can also sometimes attack itself, causing “autoimmune diseases” or immune-mediated diseases
3
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Immune System (cont’d) Participates in anaphylactic reactions Responsible for rejection of kidney, liver, and heart transplants
4
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Immunosuppressants Drugs that decrease or prevent an immune response, thus suppressing the immune system Used to prevent or treat rejection of transplanted organs
5
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Immunosuppressants (cont’d) All suppress certain T-lymphocyte cells lines, preventing their involvement in the immune response Result: a pharmacologically immunocompromised state Mechanisms of action vary according to drug
6
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Immunosuppressants (cont’d) corticosteroids Azathioprine muromonab-CD3 Daclizumab sirolimus cyclophosphamide cyclosporine tacrolimus basiliximab glatiramer acetate
7
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Immunosuppressants (cont’d) Indications vary from drug to drug Primarily indicated for the prevention of organ rejection Some also used for immunologic diseases such as rheumatoid arthritis and multiple sclerosis
8
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Immunosuppressants (cont’d) Muromonab-CD3 is the only drug indicated for reversal of organ rejection once rejection of a transplanted organ has started
9
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Immunosuppressants (cont’d) Newer drugs used to prevent organ transplant rejection mycophenolate mofetil (CellCept) daclizumab (Zenapax)* basiliximab (Simulect)* sirolimus (Rapamune) *Note that these drugs are also monoclonal antibodies (MABs)
10
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Immunosuppressants (cont’d) azathioprine (Imuran) Used as an adjunct medication to prevent rejection of kidney transplants Also used in the treatment of rheumatoid arthritis
11
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Immunosuppressants (cont’d) cyclosporine (Cyclosporin A) Primary drug used in the prevention of kidney, liver, heart, and bone marrow transplant rejection May be used for other autoimmune disorders tacrolimus (Prograf) Used only for the prevention of liver transplant rejection Others uses are unlabeled uses
12
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Immunosuppressants (cont’d) glatiramer acetate (Copaxome) The only immunosuppressant drug used for the treatment of multiple sclerosis (MS) Used to reduce the frequency of MS relapses (exacerbations) in relapsing-remitting multiple sclerosis (RRMS)
13
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Immunosuppressants (cont’d) Adverse effects vary according to drugs, and may be devastating **All immunosuppressed patients have a heightened susceptibility to opportunistic infections**
14
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications Thorough assessment should be performed before administering these drugs Renal, liver, and cardiovascular function studies CNS baseline function Respiratory assessment Baseline vital signs Baseline laboratory studies, including hemoglobin, hematocrit, WBC, and platelet counts
15
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d) Assess for contraindications, drug allergies, drug interactions Monitor WBC counts throughout therapy; if the count drops below 3000/mm 3 the drug should be discontinued, but only after contacting the physician
16
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d) Oral immunosuppressants should be taken with food to minimize GI upset Oral forms are used when possible to decrease the risk of infection that may occur with parenteral injections Note that there are several possible drug interactions Grapefruit juice also interacts with some of these drugs
17
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d) Oral antifungal drugs are usually given with these drugs to treat oral candidiasis that may occur Observe the oral cavity often for white patches on the tongue, mucous membranes, and oral pharynx
18
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d) Oral cyclosporine solution must be mixed in a glass container Styrofoam containers should not be used because the drug adheres to the inside wall of the container
19
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d) Follow guidelines for parenteral administration carefully Patients need to be told that lifelong therapy with immunosuppressants is indicated with organ transplantation
20
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d) Patients taking immunosuppressants should be encouraged to take measures to reduce the risk of infection Avoiding crowds Avoiding people with colds or other infections Patients should be told to report any fever, sore throat, chills, joint pain, fatigue, or other signs of a severe infection immediately
21
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nursing Implications (cont’d) Monitor for therapeutic responses Monitor for adverse effects and signs of drug toxicity
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.